Is U.S. Physical Therapy (USPH) overvalued or fairly valued?

MarketChacha shows U.S. Physical Therapy's valuation in context — a trailing P/E of about 42.4, a forward P/E of about 21.6, a price-to-book of about 2.4 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does U.S. Physical Therapy's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (2.34×) from reported figures — education, not a rating.

What is U.S. Physical Therapy's revenue?

U.S. Physical Therapy reported revenue of $781.0M for FY2025, with net profit of $39.6M, per official filings.

What is the share price of U.S. Physical Therapy (USPH)?

U.S. Physical Therapy last traded at $73.69 (-1.4% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

U.S. Physical Therapy

USPH · NYSE · Healthcare · United States

$73.69-1.4%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:17 PM

Snapshot

TickerUSPH

ExchangeNYSE

SectorHealthcare

IndustryMedical Care Facilities

CountryUnited States

Employees4,653

HeadquartersHouston, United States

Market cap$1.1B

P/E (TTM)42.4

P/B2.4

Volume148.3K

Websitewww.usph.com

Filings tracked6

About U.S. Physical Therapy

U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

Profile as reported by Yahoo Finance.

Who owns it

Insiders2.5%
Institutions97.5%
Public & other0.0%

336 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.14.51%
Kayne Anderson Rudnick Investment Management LLC7.00%
Morgan Stanley6.59%
Bahl & Gaynor, Inc.5.55%
Copeland Capital Management, LLC5.50%
Vanguard Capital Management LLC4.36%
State Street Corporation4.26%
Bank of America Corporation3.64%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion2.34×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend4.7% → 5.1%

Margin has held broadly steady over the period — stable profitability.

Growth qualityrev 14% · PAT 18%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $211.8M · EPS 0.80

Est. earnings growth +20.7%

Next fiscal year

Rev $895.7M · EPS 3.41

Est. earnings growth +16.7%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$58.1952-wk range$93.50

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Market cap

$1.1B

Day change

-1.4%

P/E (TTM)

42.4

Fwd P/E

21.6

P/B

2.4

Div yield

2.44%

Beta

1.14

Revenue (FY2025)

$781.0M

Net margin

5.1%

ROE

8.3%

Revenue CAGR (2y)

+13.6%

Profit CAGR (2y)

+18.4%

EPS (FY2025)

1.42

Net profit (FY2025)

$39.6M

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about USPH

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$781.0M	$39.6M	1.42	5.1%	8.3%
FY2024	$671.3M	$31.4M	1.84	4.7%	6.4%
FY2023	$604.8M	$28.2M	1.28	4.7%	5.9%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	$198.3M	$5.0M	-0.12	2.5%
2025Q3	$197.1M	$13.1M	0.48	6.7%
2025Q2	$197.3M	$12.4M	0.58	6.3%
2025Q1	$183.8M	$9.9M	0.80	5.4%
2024Q3	$168.0M	$6.6M	0.39	3.9%
2024Q2	$167.2M	$7.5M	0.47	4.5%
2024Q1	$155.7M	$8.0M	0.46	5.2%
2023Q3	$150.0M	$9.3M	0.51	6.2%
2023Q2	$151.5M	$10.9M	0.64	7.2%
2023Q1	$148.5M	$7.4M	0.58	5.0%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Other events, Exhibits
SEC7/6/2026material
8-K — Shareholder vote results
SEC5/19/2026material
8-K — Reg FD disclosure, Exhibits
SEC5/11/2026material
10-Q filing
SEC5/8/2026
8-K — Results of operations, Other events, Exhibits
SEC5/6/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC4/15/2026material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.